Investigational Drug Information for Ascomycin
✉ Email this page to a colleague
What is the development status for investigational drug Ascomycin?
Ascomycin is an investigational drug.
There have been 3 clinical trials for Ascomycin.
The most recent clinical trial was a Phase 3 trial, which was initiated on May 1st 2004.
The most common disease conditions in clinical trials are Eczema, Dermatitis, Atopic, and Dermatitis. The leading clinical trial sponsors are Novartis, University of Leipzig, and [disabled in preview].
Summary for Ascomycin
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 2,511 |
| WIPO Patent Applications | 1,213 |
| Japanese Patent Applications | 605 |
| Clinical Trial Progress | Phase 3 (2004-05-01) |
| Vendors | 0 |
Recent Clinical Trials for Ascomycin
| Title | Sponsor | Phase |
|---|---|---|
| Extension Study of Pimecrolimus Cream in Pediatric Patients With Atopic Dermatitis | Novartis | Phase 3 |
| Extension Study to Assess Safety and Efficacy of Pimecrolimus in Adult Patients With Atopic Dermatitis | Novartis | Phase 3 |
| Cutaneous Lupus Erythematosus and Elidel | Novartis | N/A |
Clinical Trial Summary for Ascomycin
Top disease conditions for Ascomycin
Top clinical trial sponsors for Ascomycin
US Patents for Ascomycin
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
